5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Applications of Non-Coding RNAs in Patients With Retinoblastoma

      review-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Retinoblastoma (RB) is the most common primary intraocular malignancy in childhood. In the carcinogenic process of neoplasms such as RB, the role of non-coding RNAs (ncRNAs) has been widely demonstrated recently. In this review, we aim to provide a clinical overview of the current knowledge regarding ncRNAs in relation to RB. Although ncRNAs are now considered as potential diagnostic biomarkers, prognostic factors, and therapeutic targets, further studies will facilitate enhanced understanding of ncRNAs in RB physiopathology and define the roles ncRNAs can play in clinical practice.

          Related collections

          Most cited references105

          • Record: found
          • Abstract: found
          • Article: not found

          Circulating microRNAs as stable blood-based markers for cancer detection.

          Improved approaches for the detection of common epithelial malignancies are urgently needed to reduce the worldwide morbidity and mortality caused by cancer. MicroRNAs (miRNAs) are small ( approximately 22 nt) regulatory RNAs that are frequently dysregulated in cancer and have shown promise as tissue-based markers for cancer classification and prognostication. We show here that miRNAs are present in human plasma in a remarkably stable form that is protected from endogenous RNase activity. miRNAs originating from human prostate cancer xenografts enter the circulation, are readily measured in plasma, and can robustly distinguish xenografted mice from controls. This concept extends to cancer in humans, where serum levels of miR-141 (a miRNA expressed in prostate cancer) can distinguish patients with prostate cancer from healthy controls. Our results establish the measurement of tumor-derived miRNAs in serum or plasma as an important approach for the blood-based detection of human cancer.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Detecting and characterizing circular RNAs.

            Circular RNA transcripts were first identified in the early 1990s but knowledge of these species has remained limited, as their study through traditional methods of RNA analysis has been difficult. Now, novel bioinformatic approaches coupled with biochemical enrichment strategies and deep sequencing have allowed comprehensive studies of circular RNA species. Recent studies have revealed thousands of endogenous circular RNAs in mammalian cells, some of which are highly abundant and evolutionarily conserved. Evidence is emerging that some circRNAs might regulate microRNA (miRNA) function, and roles in transcriptional control have also been suggested. Therefore, study of this class of noncoding RNAs has potential implications for therapeutic and research applications. We believe the key future challenge for the field will be to understand the regulation and function of these unusual molecules.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Circular intronic long noncoding RNAs.

              We describe the identification and characterization of circular intronic long noncoding RNAs in human cells, which accumulate owing to a failure in debranching. The formation of such circular intronic RNAs (ciRNAs) can be recapitulated using expression vectors, and their processing depends on a consensus motif containing a 7 nt GU-rich element near the 5' splice site and an 11 nt C-rich element close to the branchpoint site. In addition, we show that ciRNAs are abundant in the nucleus and have little enrichment for microRNA target sites. Importantly, knockdown of ciRNAs led to the reduced expression of their parent genes. One abundant such RNA, ci-ankrd52, largely accumulates to its sites of transcription, associates with elongation Pol II machinery, and acts as a positive regulator of Pol II transcription. This study thus suggests a cis-regulatory role of noncoding intronic transcripts on their parent coding genes. Copyright © 2013 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Genet
                Front Genet
                Front. Genet.
                Frontiers in Genetics
                Frontiers Media S.A.
                1664-8021
                31 March 2022
                2022
                : 13
                : 842509
                Affiliations
                [1] 1 Department of Ophthalmology , University Hospital of Santiago de Compostela , Santiago de Compostela, Spain
                [2] 2 Tumores Intraoculares en el Adulto , Instituto de Investigación Sanitaria de Santiago (IDIS) , Santiago de Compostela, Spain
                [3] 3 Department of Ophthalmology , University Hospital of Cruces , Barakaldo, Spain
                [4] 4 Fundación Pública Galega de Medicina Xenómica , Clinical University Hospital , Santiago de Compostela, Spain
                [5] 5 Department of Ophthalmology , University Hospital of Coruña , A Coruña, Spain
                [6] 6 Grupo Obesidómica , Instituto de Investigación Sanitaria de Santiago (IDIS) , Santiago de Compostela, Spain
                Author notes

                Edited by: Shigeo Yoshida, Kurume University, Japan

                Reviewed by: Zi-Bing Jin, Capital Medical University, China

                *Correspondence: Manuel Bande, manuelfran.bande@ 123456rai.usc.es

                This article was submitted to RNA, a section of the journal Frontiers in Genetics

                Article
                842509
                10.3389/fgene.2022.842509
                9008704
                99ce94ce-4be3-46a3-9431-ab76d88b2275
                Copyright © 2022 Fernandez-Diaz, Rodriguez-Vidal, Silva-Rodríguez, Paniagua, Blanco-Teijeiro, Pardo, Piñeiro and Bande.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 23 December 2021
                : 07 March 2022
                Funding
                Funded by: Instituto de Salud Carlos III , doi 10.13039/501100004587;
                Categories
                Genetics
                Review

                Genetics
                retinoblastoma,non-coding rna,lncrna,mirna,circrna,diagnostic biomarker,prognostic factor,therapeutic target

                Comments

                Comment on this article